Toll-like receptor 3 (TLR3) also known as CD283 (cluster of differentiation 283) is a protein that in humans is encoded by the TLR3 gene. TLR3 is a member of the toll-like receptor family of pattern recognition receptors of the innate immune system. TLR3 recognizes double-stranded RNA in endosomes, which is a common feature of viral genomes internalised by macrophages and dendritic cells.
Structure Toll-like receptor 3 (TLR3) is a type I transmembrane receptor consisting of an extracellular ectodomain (PF13855, PF13516), a single transmembrane helix (PF17968), and a cytoplasmic Toll/interleukin-1 receptor (TIR) signaling domain (PF01582). Its ectodomain forms a large horseshoe-shaped solenoid built from 23 leucine-rich repeats (LRRs), each stabilized by conserved asparagine residues that create extensive hydrogen-bonding networks along the coil, with specialized N- and C-terminal cap domains closing off the horseshoe's ends.
Function TLR3 is a member of the toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of IRF3 and NF-κB. Unlike other TLRs, TLR3 uses TRIF as the sole adaptor. IRF3 ultimately induces the production of type I interferons. It may thus play a role in host defense against viruses. TLR3 recognizes double-stranded RNA, a form of genetic information carried by some viruses such as reoviruses. Additionally, an ephemeral form of double-stranded RNA exists as a replicative intermediate during virus replication. Upon recognition, TLR3 induces the activation of IRF3 to increase production of type I interferons which signal other cells to increase their antiviral defenses. Double-stranded RNA is also recognised by the cytoplasmic receptors RIG-I and MDA-5. TLR3 displays a protective role in mouse models of atherosclerosis, and activation of TLR3 signaling is associated with ischemic preconditioning-induced protection against brain ischemia and attenuation of reactive astrogliosis. Furthermore, TLR3 activation has been shown to promote hair follicle regeneration in skin wound healing. In addition, TLR3 activators show effects on human vascular cells.
Ligands Agonists Natural dsRNA, from viruses and some dead cells Synthetic dsRNA such as poly(I:C), poly(A:U), RGC100, NexaVant Endogenous mRNA, presumably due to secondary structure (stems resemble dsRNA) PVP-057 (small molecule) Various minibinder proteins (allosteric) Antagonists CU-CPT4a (competitive) There is a minimum dsRNA size required to effectively trigger TLR3. This size is lower than the activation threshold for MDA5, another dsRNA sensor with higher inflammatory and cytotoxic potential. As a result, synthetic dsRNA can be made to avoid MDA5 activation by controlling the size of the molecule.
References
Further reading
This article incorporates text from the United States National Library of Medicine, which is in the public domain.






